Wosulin-R Disp Pen

Composition of Wosulin-R Disp Pen

Wosulin-R Disp Pen contains Human Insulin (Regular) Injection 100 IU/mL (rDNA origin). It belongs to the Short-acting insulin (Regular human insulin) class of medicines.

Uses of Wosulin-R Disp Pen

Treatment of diabetes mellitus (Type 1 diabetes; Type 2 diabetes when insulin is required) to control blood glucose; management of hyperglycaemia in hospital settings as advised by doctor

Key benefits

• Controls high blood sugar
• reduces diabetes complications risk
• helps manage mealtime glucose excursions
• flexible dosing under medical supervision
• suitable for Type 1 and insulin-requiring Type 2 diabetes

How Wosulin-R Disp Pen works

Regular human insulin replaces/supplements endogenous insulin. It helps glucose enter muscle and fat cells and reduces glucose production by the liver, thereby lowering blood sugar levels.

How to take Wosulin-R Disp Pen

For subcutaneous injection using the prefilled disposable pen as prescribed by a doctor. Regular insulin is typically taken about 30 minutes before meals; rotate injection sites (abdomen/thigh/upper arm) and do not inject into areas that are red, swollen or lumpy. Do not share the pen; use a new needle for each injection and follow pen priming/usage instructions.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Contact your doctor or diabetes nurse for advice — do not take a double dose to make up for a missed injection.

If you take too much

An overdose of this medicine can cause severe low blood sugar, leading to fits or unconsciousness — this is a medical emergency. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.

Side effects of Wosulin-R Disp Pen

Most side effects of Wosulin-R Disp Pen are mild and settle as the body adjusts. Reported side effects include:

• Hypoglycaemia (low blood sugar)
• injection site reactions (pain/redness/swelling)
• weight gain
• skin thickening or pits at injection site (lipodystrophy)
• rash
• itching
• peripheral oedema

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Wosulin-R Disp Pen

Warnings and precautions

Risk of hypoglycaemia—carry glucose/sugar and know symptoms (sweating, tremor, confusion). Dose needs adjustment with changes in diet, exercise, illness, kidney/liver impairment, or switching insulin products. Do not use during episodes of hypoglycaemia or if allergic to insulin/excipients. Use caution while driving/operating machinery if prone to low sugars. Rotate sites to reduce lipodystrophy. Monitor blood glucose regularly; seek medical help for severe hypoglycaemia or persistent hyperglycaemia/ketosis.

Do not take Wosulin-R Disp Pen if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Not to be used during an episode of low blood sugar.

Interactions with other medicines

Other antidiabetics (additive hypoglycaemia),beta-blockers (may mask hypoglycaemia),ACE inhibitors (may increase hypoglycaemia risk),corticosteroids/thiazide diuretics/thyroid hormones/sympathomimetics (may increase blood glucose),MAO inhibitors (increase hypoglycaemia risk),alcohol (can cause hypo- or hyperglycaemia)

How to store Wosulin-R Disp Pen

Store unopened pens refrigerated at 2–8°C; do not freeze. Protect from light. After first use, store as per pack insert (commonly below 25–30°C) and use within the recommended in-use period; keep cap on when not in use. Keep out of reach of children.

Expert advice for Wosulin-R Disp Pen

Keep an unopened supply in the fridge and the pen in use at room temperature, away from direct sunlight. Always carry a fast-acting sugar source. Check your sugar as your doctor has instructed, and keep a record to take to appointments.

Manufacturer and class

Manufacturer:

WOCHARDT PHARMA

Therapeutic class:

Antidiabetic

Drug class:

Short-acting insulin (Regular human insulin)